These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

352 related items for PubMed ID: 32962135

  • 1. Obinutuzumab-Induced B Cell Depletion Reduces Spinal Cord Pathology in a CD20 Double Transgenic Mouse Model of Multiple Sclerosis.
    Breakell T, Tacke S, Schropp V, Zetterberg H, Blennow K, Urich E, Kuerten S.
    Int J Mol Sci; 2020 Sep 18; 21(18):. PubMed ID: 32962135
    [Abstract] [Full Text] [Related]

  • 2. Effects of a Fully Humanized Type II Anti-CD20 Monoclonal Antibody on Peripheral and CNS B Cells in a Transgenic Mouse Model of Multiple Sclerosis.
    Tacke S, Chunder R, Schropp V, Urich E, Kuerten S.
    Int J Mol Sci; 2022 Mar 15; 23(6):. PubMed ID: 35328594
    [Abstract] [Full Text] [Related]

  • 3. Time-Dependent Progression of Demyelination and Axonal Pathology in MP4-Induced Experimental Autoimmune Encephalomyelitis.
    Prinz J, Karacivi A, Stormanns ER, Recks MS, Kuerten S.
    PLoS One; 2015 Mar 15; 10(12):e0144847. PubMed ID: 26658811
    [Abstract] [Full Text] [Related]

  • 4. Early axonal damage and progressive myelin pathology define the kinetics of CNS histopathology in a mouse model of multiple sclerosis.
    Recks MS, Stormanns ER, Bader J, Arnhold S, Addicks K, Kuerten S.
    Clin Immunol; 2013 Oct 15; 149(1):32-45. PubMed ID: 23899992
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Enhanced visualization of axonopathy in EAE using thy1-YFP transgenic mice.
    Bannerman PG, Hahn A.
    J Neurol Sci; 2007 Sep 15; 260(1-2):23-32. PubMed ID: 17493638
    [Abstract] [Full Text] [Related]

  • 7. Distinct pathological patterns in relapsing-remitting and chronic models of experimental autoimmune enchephalomyelitis and the neuroprotective effect of glatiramer acetate.
    Aharoni R, Vainshtein A, Stock A, Eilam R, From R, Shinder V, Arnon R.
    J Autoimmun; 2011 Nov 15; 37(3):228-41. PubMed ID: 21752599
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Efficient Distribution of a Novel Zirconium-89 Labeled Anti-cd20 Antibody Following Subcutaneous and Intravenous Administration in Control and Experimental Autoimmune Encephalomyelitis-Variant Mice.
    Migotto MA, Mardon K, Orian J, Weckbecker G, Kneuer R, Bhalla R, Reutens DC.
    Front Immunol; 2019 Nov 15; 10():2437. PubMed ID: 31681317
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Fundamental differences in the dynamics of CNS lesion development and composition in MP4- and MOG peptide 35-55-induced experimental autoimmune encephalomyelitis.
    Kuerten S, Javeri S, Tary-Lehmann M, Lehmann PV, Angelov DN.
    Clin Immunol; 2008 Nov 15; 129(2):256-67. PubMed ID: 18722816
    [Abstract] [Full Text] [Related]

  • 14. Mannan-MOG35-55 Reverses Experimental Autoimmune Encephalomyelitis, Inducing a Peripheral Type 2 Myeloid Response, Reducing CNS Inflammation, and Preserving Axons in Spinal Cord Lesions.
    Dagkonaki A, Avloniti M, Evangelidou M, Papazian I, Kanistras I, Tseveleki V, Lampros F, Tselios T, Jensen LT, Möbius W, Ruhwedel T, Androutsou ME, Matsoukas J, Anagnostouli M, Lassmann H, Probert L.
    Front Immunol; 2020 Nov 15; 11():575451. PubMed ID: 33329540
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Autoreactive CD19+CD20- Plasma Cells Contribute to Disease Severity of Experimental Autoimmune Encephalomyelitis.
    Chen D, Ireland SJ, Davis LS, Kong X, Stowe AM, Wang Y, White WI, Herbst R, Monson NL.
    J Immunol; 2016 Feb 15; 196(4):1541-9. PubMed ID: 26764035
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.